miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.

Mol Cancer · 2014 · PMC4234346 · PMID 24655723

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Here we found that although a trend towards an increase in IGF1R mRNA existed following miR-630 inhibition compared to the negative control (Additional file 1 : Figure S2), this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.